OtherIMMUNOPHARMACOLOGY
Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding ofN-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
Silvina Raiden, Mirta Giordano, Graciela Andonegui, Analía S. Trevani, Daniel H. López, Victor Nahmod and Jorge R. Geffner
Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 624-628;
Silvina Raiden
Mirta Giordano
Graciela Andonegui
Analía S. Trevani
Daniel H. López
Victor Nahmod
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 281, Issue 2
1 May 1997
OtherIMMUNOPHARMACOLOGY
Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding ofN-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
Silvina Raiden, Mirta Giordano, Graciela Andonegui, Analía S. Trevani, Daniel H. López, Victor Nahmod and Jorge R. Geffner
Journal of Pharmacology and Experimental Therapeutics May 1, 1997, 281 (2) 624-628;
OtherIMMUNOPHARMACOLOGY
Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding ofN-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
Silvina Raiden, Mirta Giordano, Graciela Andonegui, Analía S. Trevani, Daniel H. López, Victor Nahmod and Jorge R. Geffner
Journal of Pharmacology and Experimental Therapeutics May 1, 1997, 281 (2) 624-628;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement